Inventor · disambiguated record
Ryuichi Morishita
Also filed as: MORISHITA RYUICHI
48 granted patents·52 pending applications·371 citations·filing 1995–2024
98Inventor score
Top patents by PatentIndex Score
100 records- 0193US7816511B2Remedies for heart failureASUBIO PHARMA CO LTD·Filed 2003·Granted Oct 19, 2010·96 cites·14 claims
- 0290US6821956B2Therapeutic use of cis-element decoys in vivoBRIGHAM & WOMENS HOSPITAL·Filed 2001·Granted Nov 23, 2004·27 cites·4 claims
- 0388US10112978B2Peptide and use thereofUNIV OSAKA·Filed 2015·Granted Oct 30, 2018·4 cites·20 claims
- 0488US6262033B1Remedy for diseases associated with NF-κBFUJISAWA PHARMACEUTICAL CO·Filed 1996·Granted Jul 17, 2001·80 cites·6 claims
- 0588US2025090634A1Lymphangiogenesis-promoting agentsANGES INC·Filed 2024·Application pending·0 cites
- 0684US7285540B2Medicament comprising HGF geneANGES MG INC·Filed 2003·Granted Oct 23, 2007·20 cites·4 claims
- 0783US8017119B2Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involvedDAIICHI SANKYO CO LTD·Filed 2008·Granted Sep 13, 2011·8 cites·24 claims
- 0882US10517926B2Oligopeptide having proinflammatory cytokine secretion-inhibiting activityUNIV OSAKA·Filed 2016·Granted Dec 31, 2019·3 cites·8 claims
- 0980US10980876B2Conjugate vaccine targeting a disease-causing biological proteinUNIV OSAKA·Filed 2017·Granted Apr 20, 2021·1 cites·10 claims
- 1080US9913886B2DNA vaccine containing specific epitope of apolipoprotein (a)ANGES INC·Filed 2016·Granted Mar 13, 2018·5 cites·22 claims
- 1180US8372957B2Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involvedDAIICHI SANKYO CO LTD·Filed 2011·Granted Feb 12, 2013·5 cites·12 claims
- 1279US9872825B2Peptide with anti-aging effect and use thereofUNIV OSAKA·Filed 2014·Granted Jan 23, 2018·4 cites·23 claims
- 1376US11819537B2Preventive or therapeutic method for inflammatory skin diseaseUNIV OSAKA·Filed 2017·Granted Nov 21, 2023·1 cites·9 claims
- 1476US6989374B1Gene therapy for cardiomyopathyANGES MG INC·Filed 2000·Granted Jan 24, 2006·11 cites·4 claims
- 1576US6774118B1Therapeutic use of CIS-element decoys in vivoBRIGHAM & WOMENS HOSPITAL·Filed 1995·Granted Aug 10, 2004·26 cites·1 claims
- 1675US7994151B2Compositions and methods for angiogenic therapy utilizing genes encoding ets-1ANGES MG INC·Filed 2009·Granted Aug 9, 2011·1 cites·12 claims
- 1775US7247620B2Method of treating skin wounds with vectors encoding hepatocyte growth factorANGES MG INC·Filed 2002·Granted Jul 24, 2007·6 cites·7 claims
- 1874US7595301B2Staple type oligonucleotide and drug comprising the sameANGES MG INC·Filed 2004·Granted Sep 29, 2009·12 cites·3 claims
- 1974US6936594B1Gene therapy for cerebrovascular disordersANGES MG INC·Filed 2000·Granted Aug 30, 2005·8 cites·5 claims
- 2073US7504098B2Method for introducing a biological molecule using a viral envelope and heparin and system thereforeANGES MG INC·Filed 2005·Granted Mar 17, 2009·2 cites·2 claims
- 2173US6248722B1Medicament comprising HGF geneMEDGENE BIOSCIENCE INC·Filed 1996·Granted Jun 19, 2001·36 cites·6 claims
- 2273US2022088141A1Lymphangiogenesis-promoting agentsANGES INC·Filed 2021·Application pending·0 cites
- 2371US11453880B2Chimeric decoyANGES INC·Filed 2016·Granted Sep 27, 2022·1 cites·9 claims
- 2471US9446120B2DNA vaccineMORISHITA RYUICHI·Filed 2012·Granted Sep 20, 2016·1 cites·11 claims
- 2571US7871983B2Remedy and preventive for diseases caused by NF-κBANGES MG INC·Filed 2003·Granted Jan 18, 2011·2 cites·14 claims
- 2671US7524830B2Decoy-containing pharmaceutical compositions and method of using the sameANGES MG INC·Filed 2006·Granted Apr 28, 2009·1 cites·3 claims
- 2770US10543261B2DNA vaccine containing VEGF-specific epitope and/or angiopoietin-2-specific epitopeUNIV OSAKA·Filed 2013·Granted Jan 28, 2020·1 cites·18 claims
- 2870US7763591B2Hepatocyte growth factor gene therapy for parkinson's diseaseANGES MG INC·Filed 2002·Granted Jul 27, 2010·4 cites·12 claims
- 2969US12070498B2Conjugate vaccine targeting a disease-causing biological proteinUNIV OSAKA·Filed 2021·Granted Aug 27, 2024·0 cites·9 claims
- 3068US10695420B2DNA-peptide combination vaccineANGES INC·Filed 2015·Granted Jun 30, 2020·1 cites·14 claims
- 3168US2011160132A1Lymphangiogenesis-promoting agentsANGES MG INC·Filed 2006·Application pending·0 cites
- 3267US7939504B2Method of treating skin ulcers with vectors encoding hepatocyte growth factorANGES MG INC·Filed 2007·Granted May 10, 2011·0 cites·7 claims
- 3366US2019321444A1Lymphangiogenesis-promoting agentsANGES INC·Filed 2019·Application pending·0 cites
- 3464US10233215B2Peptide and use thereofUNIV OSAKA·Filed 2018·Granted Mar 19, 2019·0 cites·8 claims
- 3564US8969311B2Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptideGEMBA TAKEFUMI·Filed 2010·Granted Mar 3, 2015·1 cites·17 claims
- 3663US7390482B2Drug for auditory dysfunctionANGES MG INC·Filed 2003·Granted Jun 24, 2008·1 cites·2 claims
- 3763US2025057928A1Vaccine composition for inducing anti-il-23 antibodyUNIV OSAKA·Filed 2022·Application pending·0 cites
- 3862US8067388B2Decoy-containing pharmaceutical compositions and method of using the sameMORISHITA RYUICHI·Filed 2009·Granted Nov 29, 2011·0 cites·6 claims
- 3962US7259149B2Methods for treating or preventing angiogenesis-dependent symptomsANGES MG INC·Filed 2003·Granted Aug 21, 2007·2 cites·4 claims
- 4060US9889186B2Oral vaccine having improved cellular immunity induction potencyANGES MG INC·Filed 2014·Granted Feb 13, 2018·0 cites·16 claims
- 4160US2009004260A1Medicament comprising hgf geneANGES MG INC·Filed 2008·Application pending·0 cites
- 4259US2004229833A1Therapeutic use of cis-element decays in vivoFiled 2004·Application pending·0 cites
- 4358US2008268030A1Gene therapy for diabetic ischemic diseaseMEDGENE BIOSCIENCE INC·Filed 2008·Application pending·0 cites
- 4457US2025042982A1Antibody or antigen-binding fragment thereofUNIV OSAKA·Filed 2022·Application pending·0 cites
- 4557US2011045061A1Gene therapy for diabetic ischemic diseaseANGES MG INC·Filed 2010·Application pending·0 cites
- 4657US2009105183A1Pharmaceutical composition containing decoy and method of using the sameANGES MG INC·Filed 2008·Application pending·0 cites
- 4756US9376470B2Polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposesGEMBA TAKEFUMI·Filed 2009·Granted Jun 28, 2016·0 cites·29 claims
- 4856US2016271219A1Lymphangiogenesis-promoting agentsANGES MG INC·Filed 2016·Application pending·0 cites
- 4956US2003186922A1Therapeutic use of cis-element decoys in vivoFiled 2003·Application pending·0 cites
- 5056US2023374103A1Wnt SIGNALING PATHWAY INHIBITORUNIV OSAKA·Filed 2021·Application pending·0 cites
Showing the top 50 of 100 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ryuichi Morishita files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →